• News

    Alendronate Therapy Lowers Risk of Hip Fractures

    July 15, 2016

    NEW YORK - Long-term use of the bisphosphonate alendronate substantially lowers the risk of hip fracture without increasing the risk of atypical fractures of the subtrochanteric femur or femoral shaft, according to a Danish study. "These findings support an acceptable balance between benefit and